Breathe Well Live Well
|
FDA advisers recommend approval of asthma drug for adults
Pharmacy Today, American Pharmacists Association, pharmacist.com An FDA advisory committee has recommended the agency approve Teva Pharmaceutical's experimental drug reslizumab for severe asthma in patients aged 18 years and older. Reslizumab is an antibody drug designed to be given intravenously once every … |
View full post on asthma – Google News
Fox News |
FDA advisers recommend approval of Teva asthma drug in adults
Fox News An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's. The panel voted unanimously that the drug should not be approved for children aged 12 to 17. US FDA advisers recommend approval of Teva asthma drug for adults FDA Advisory Committee Recommends Approval of Teva's Asthma Biologic Reslizumab |
View full post on asthma – Google News
Reuters |
US FDA advisers recommend approval of Teva asthma drug for adults
Reuters An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's <TEVA.TA) experimental drug reslizumab for severe asthma in patients aged 18 and older. Ad Comm tomorrow for Teva's asthma candidate reslizumab |
View full post on asthma – Google News
Medscape |
GlaxoSmithKline's new asthma drug gets a split vote from FDA advisers
FierceBiotech GSK's injection, mepolizumab, works by blocking the protein interleukin-5 to prevent buildups of white blood cells in the lungs that can exacerbate asthma. The company is angling to get the drug approved as a treatment for sufferers of severe asthma … FDA Panel Backs Mepolizumab for Severe Eosinophilic Asthma GlaxoSmithKline plc (ADR) Wins FDA Panel Backing For Severe Asthma Drug Asthma Drug Targeting IL-5 Wins Partial Backing From FDA Advisers |
View full post on asthma – Google News